Patient Login

HeliTrax^® for Hemophilia A Patients

Manage your treatment of hemophilia A. At a time that’s best for you.

The state-of-the-art design of the HeliTrax System can help you partner with your treatment team to better manage your hemophilia together. With new features and enhancements, the HeliTrax System makes it even easier for you to stay on top of treatment on your own time. The HeliTrax System can also help your treatment team prepare for your next visit.

A Web interface tracks treatment in real time

With the HeliTrax System, you can record your treatment progress and keep in touch with your treatment team wherever a computer with online access is available. This interface mirrors what you see on your handheld electronic diary.

Analyze, organize, and print your treatment data
Maintain a record of other types of medications used for your treatment of hemophilia A

An e-diary keeps treatment close at hand

Your wireless, handheld electronic diary works anywhere a cell phone does. This helps you and your treatment team manage your care anytime, anywhere. Now you have a more complete picture of your treatment with two-way communication and free Internet access. And it’s easier to notify your treatment team about emergency hemophilia A symptoms (i.e., bleeding events).

Use one handheld electronic diary to store information for many family members
Quickly report and capture emergency bleeding events with the HeliTrax System built-in camera
Save time with intelligent e-forms that automatically fill in repetitive data and make it easier for you to quickly record new data, such as hemophilia A symptoms
Automatically track medication use and inventory

Safe, secure, and there when a patient needs it for treatment of hemophilia A

Privacy standards and around-the-clock support provide added peace of mind.

Meets HIPAA standards, keeping your information securely hosted
Provides a JCAHO-compliant progress report of your medical records for healthcare professionals
Includes a 24-hour support line to call for answers to any system-related questions

CSL Behring cannot access patient data collected by the HeliTrax System. All data are stored by an independent third-party organization.

“Using HeliTrax helps empower my son to take control of his bleeding disorder and treatment. He is now keeping better track of his treatment regimen by remaining in communication with the treatment center.”
— Kristin P., whose 14-year-old son currently uses the HeliTrax System

To speak with a live representative about the HeliTrax System, call the HeliTrax System helpdesk at 1-800-598-6445.

Next: HeliTrax^®for Healthcare Professional »

Important Safety Information

Helixate^® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Helixate^® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to antihemophilic factor. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Helixate^® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

Please see the full prescribing information.